PELUSO, ROSARIO
 Distribuzione geografica
Continente #
AS - Asia 5.643
NA - Nord America 5.497
EU - Europa 4.229
SA - Sud America 672
Continente sconosciuto - Info sul continente non disponibili 294
AF - Africa 136
OC - Oceania 10
Totale 16.481
Nazione #
US - Stati Uniti d'America 5.249
SG - Singapore 2.609
RU - Federazione Russa 1.723
IT - Italia 1.077
VN - Vietnam 1.026
CN - Cina 1.008
BR - Brasile 536
HK - Hong Kong 469
FR - Francia 253
UA - Ucraina 237
DE - Germania 221
FI - Finlandia 184
NL - Olanda 136
IE - Irlanda 135
CA - Canada 128
BD - Bangladesh 112
GB - Regno Unito 101
JP - Giappone 74
IN - India 67
MX - Messico 57
AR - Argentina 51
IQ - Iraq 48
CI - Costa d'Avorio 41
ZA - Sudafrica 41
SE - Svezia 39
PL - Polonia 27
TH - Thailandia 27
PH - Filippine 26
ES - Italia 23
PK - Pakistan 23
EC - Ecuador 20
VE - Venezuela 20
TR - Turchia 19
TW - Taiwan 17
KR - Corea 16
JM - Giamaica 14
CO - Colombia 13
CR - Costa Rica 12
ID - Indonesia 12
LT - Lituania 11
PY - Paraguay 11
SA - Arabia Saudita 11
AT - Austria 10
CZ - Repubblica Ceca 10
LB - Libano 9
TN - Tunisia 9
UY - Uruguay 9
CH - Svizzera 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
AZ - Azerbaigian 7
MA - Marocco 7
NP - Nepal 7
JO - Giordania 6
KE - Kenya 6
ET - Etiopia 5
GT - Guatemala 5
MY - Malesia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
CL - Cile 4
EG - Egitto 4
HN - Honduras 4
HR - Croazia 4
OM - Oman 4
PE - Perù 4
AM - Armenia 3
BB - Barbados 3
BZ - Belize 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AD - Andorra 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
EU - Europa 2
GE - Georgia 2
GF - Guiana Francese 2
GH - Ghana 2
GR - Grecia 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
Totale 16.164
Città #
Singapore 1.210
San Jose 780
Ashburn 512
Hong Kong 448
Moscow 428
Chandler 384
Ho Chi Minh City 306
Beijing 259
Santa Clara 227
Hanoi 211
Millbury 164
The Dalles 162
Jacksonville 152
Naples 141
Princeton 139
Lauterbourg 136
Council Bluffs 135
Nanjing 120
Los Angeles 112
Boston 108
Amsterdam 107
Buffalo 78
Napoli 72
New York 71
Rome 71
Munich 66
Tokyo 63
Milan 58
São Paulo 58
Wilmington 57
Dallas 56
Redondo Beach 52
Boardman 51
Des Moines 50
Da Nang 47
Hefei 46
Ottawa 46
Haiphong 45
Nanchang 42
Phoenix 42
Houston 33
Chicago 31
Orem 31
Hải Dương 30
Seattle 29
Turku 29
Mexico City 28
Bari 26
Brooklyn 26
Hebei 26
Jiaxing 26
Frankfurt am Main 25
Helsinki 24
Biên Hòa 23
Lawrence 23
Atlanta 22
Norwalk 22
Denver 21
Tianjin 21
Toronto 21
Warsaw 21
Montreal 20
Shenyang 19
Dhaka 17
Baghdad 16
Dublin 16
Washington 16
Campinas 15
Chennai 15
Falkenstein 15
Johannesburg 15
Changsha 14
Manchester 14
Palermo 14
Stockholm 14
London 13
Poplar 13
Redwood City 13
Rio de Janeiro 13
Florence 12
Guangzhou 12
Falls Church 11
Can Tho 10
Hangzhou 10
Nuremberg 10
Padova 10
Bangkok 9
Bến Tre 9
Montevideo 9
Porto Alegre 9
Belo Horizonte 8
Brasília 8
Cava de' Tirreni 8
Fortaleza 8
Kunming 8
New Delhi 8
San Francisco 8
San José 8
Turin 8
Venice 8
Totale 8.313
Nome #
Artrite Psoriasica 778
Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies 176
Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies 168
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: A randomised, controlled, crossover study 163
Nail and Distal Interphalangeal Joint in Psoriatic Arthritis. 162
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 153
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs. 152
Markers of cardiovascular risk in patients with antiphospholipid syndrome: A meta-analysis of literature studies 147
Management of arthropathy in inflammatory bowel diseases 147
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study 147
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. 146
Artrite psoriasica resistente a più DMARDs. 144
Il methotrexate nella terapia dell'artrite periferica in corso di rettocolite ulcerosa 143
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? 142
Nuovi farmaci nell'artrite psoriasica. Etanercept. 138
Ankylosing spondylitis and posture control: The role of visual input 136
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. 135
The impact of concomitant diffuse idiopathic skeletal hyperostosis on the achievement of minimal disease activity in subjects with psoriatic arthritis 135
Cardiovascular effects of Etanercept in patients with psoriatic arthritis: Evidence from the cardiovascular risk in rheumatic diseases database 134
Subclinical atherosclerosis in patients with rheumatoid arthritis: A meta-analysis of literature studies 131
Small molecule therapy for managing moderate to severe psoriatic arthritis 130
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies 130
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 128
Dactylitis in enteropathic spondyloarthritis 126
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 126
Magnetic resonance imaging of nail unit in psoriatic arthritis 126
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy 125
Clinical presentation of Psoriatic Arthritis. 125
contributo di ricerca 125
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 125
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 124
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 124
Psoriasi, artrite psoriasica o malattia psoriasica. 123
Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole. 123
Is the involvement of distal interphalangeal joint of psoriatic pateints related to nail psoriasis? 121
La gravidanza nelle malattie autoimmuni: il rischio per la madre, per il feto e per il neonato. 121
Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. 121
Hepatic steatosis, carotid plaques and achieving MDA in psoriaticarthritis patients starting TNF-alpha blockers treatment: a prospective study. 121
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 120
Screening and Monitoring of Latent Tubercular Infection in Patients Taking Tumor Necrosis Factor-α Blockers for Psoriatic Arthritis 120
Extra-articular manifestations in psoriatic arthritis patients 120
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 120
Clinical and genetic aspects of psoriatic arthritis "sine psoriasis" 118
Consecutive occurrence of rhinoconjunctivitis, seronegative spondyloarthritis and pyoderma gangrenosum in a patient with ulcerative colitis. 118
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study 118
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study 117
Infliximab in the treatment of seronegative spondyloarthropathies 114
Clinical presentation of psoriatic arthritis. 114
contributo di ricerca 114
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study 114
Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. 113
contributo di ricerca 113
Epidemiologia ed aspetti socioeconomici dell’osteoporosi. 112
Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies 112
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 112
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations 111
contributo di ricerca 110
contributo di ricerca 109
Psoriasis is not a risk factor for arthritis in patients with Crohn’s disease Rheumatology, 41:115, 2002. 108
Enteropathic spondyloarthritis: from diagnosis to treatment. 108
R.SCARPA, E.COSENTINI, F.MANGUSO, A.ORIENTE, R.PELUSO, F.AYALA, P.ORIENTE Psoriarit arthritis “sine psoriasis” clinical and genetical aspects Rheumatology 42: (P103)53 , 2003. 107
Rapporto intestino e spondiloartriti: dubbi e certezze 107
OBESITY AND PSORIATIC ARTHRITIS: FROM PATHOGENESIS TO CLINICAL OUTCOME AND MANAGEMENT 107
Discovertebral Erosions in Patients with Enteropathic Spondyloarthritis. 107
Carotid intima-media thickness in psoriatic arthritis: Differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs 107
Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis 106
Comparison of efficacy and safety of infliximab (INF), etanercept (ETN) and adalimumab (ADA) in psoriatic arthritis patients who experienced an inadequate response to previous disease modifying antirheumatic drugs 105
Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers 104
New developments in magnetic resonance imaging of the nail unit. 104
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. 102
IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report. 102
Artrite Psoriasica 101
Il fumo e l’appendicectomia sono fattori di rischio per lo sviluppo di manifestazioni extraintestinali nella rettocolite ulcerosa. AnnI t Med Int 18:9S, 2003. 100
Spondiloartrosi sieronegative e patologia allergica nei pazienti con rettocolite ulcerosa 100
L’appendicectomia ritarda l’esordio clinico della rettocolite ulcerosa ma favorisce la comparsa di manifestazioni extraintestinali. 100
Association of MICA alleles with psoriatic arthritis and its clinical forms. A Multicenter Italian study. 100
Spondiloartriti sieronegative e patologia allergica nei pazienti con rettocolite ulcerosa. 97
Cardiovascular Risk in Rheumatic Patients: The Link between Inflammation and Atherothrombosis. 96
Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis 96
Artrite psoriasica 95
– Le Spondiloartriti: dalla diagnosi al trattamento 94
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 94
Ankylosing spondylitis: clinical aspects and diagnosis 93
Artrite Psoriasica "sine Psoriasi" 92
Emerging drugs for psoriatic arthritis 91
Coeliac disease is a risk factor for the development of seronegative arthritis in patients with autoimmune thyroid disease 90
Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study 89
Le raccomandazioni terapeutiche per l’uso degli anti TNF-alfa nell’artrite psoriasica e le evidenze della pratica clinica quotidiana 88
Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration 88
TNFα-inhibitors for ankylosing spondylitis and nonradiographic axial spondyloarthritis 88
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave 88
Artrite Psoriasica 87
Le manifestazioni extra-articolari in corso di spondiloartrite. 87
[Seronegative spondyloarthropathies and allergic diseases in patients with ulcerative colitis]. 87
The early treatment of psoriatic arthritis 87
Articular and other immune-mediated extra-intestinal manifestations in inflammatory bowel diseases 85
Incidence of malignancies in a cohort of psoriatic arthritis patients taking traditional disease modifying antirheumatic drug and tumor necrosis factor inhibitor therapy: An observational study 85
Leflunomide in psoriatic polyarthropathis 84
Treatment of psoriatic arthritis 83
E’ possibile caratterizzare sul piano clinico ed immunogenetico l’artrite psoriasica sine psoriasi? 81
Totale 12.140
Categoria #
all - tutte 56.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022858 0 0 10 6 6 17 13 34 132 78 185 377
2022/2023963 169 61 26 73 105 121 7 88 146 110 44 13
2023/2024916 24 104 115 63 56 92 35 81 20 42 159 125
2024/20254.001 227 268 23 60 88 193 427 253 326 396 1.356 384
2025/20267.361 892 454 704 623 1.291 364 746 455 1.019 467 161 185
2026/2027641 169 272 200 0 0 0 0 0 0 0 0 0
Totale 16.481